Загрузка...
Severe bilateral panuveitis during melanoma treatment by Dabrafenib and Trametinib
BACKGROUND: We report a case of severe bilateral panuveitis during melanoma therapy with a combination of Dabrafenib, a B-raf (BRAF) inhibitor, and Trametinib, a mitogen/extracellular signal-regulated kinase (MEK) inhibitor. Both of these drugs are effectors in the mitogen-activated protein kinase (...
Сохранить в:
| Опубликовано в: : | J Ophthalmic Inflamm Infect |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Berlin Heidelberg
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4460117/ https://ncbi.nlm.nih.gov/pubmed/26078801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12348-015-0049-9 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|